Hims & Hers Health stock analysis: revenue up 38%, but losses, an FTC lawsuit and a faulty cash flow figure keep the model at Hold.
Hold
-
-
ChemicalsUS Stocks
Sherwin-Williams Grew Earnings 14% Last Quarter, Yet Its Shares Sit Near Two-Year Lows at 29 Times Earnings
Sherwin-Williams stock analysis: earnings up 14% last quarter, but shares near two-year lows still trade at 29 times earnings. Why the model says Hold.
-
Interactive Media & ServicesUS Stocks
Spotify Has 300 Million Subscribers and Record Margins, Yet Trades a Third Below Its Two-Year High
Spotify Technology S.A. stock analysis: a record 33.4% gross margin and 300M subscribers, but a P/E near 30 keeps the model at Hold.
-
HardwareUS Stocks
HPE Has Climbed More Than Fivefold From Its Two-Year Low on AI Servers and Juniper – the Model Still Rates It Hold
Hewlett Packard Enterprise stock analysis: HPE hits a two-year high on AI servers and networking, but a P/E of 36.37 keeps the model at Hold.
-
Electric UtilitiesUS Stocks
PG&E Trades at 0.84 Times Book After California’s Wildfire Bill Collapsed – the Model Rates It Hold
PG&E stock analysis: shares trade at 0.84x book near a two-year low after California’s wildfire bill failed; the model’s signal is Hold.
-
Semiconductor EquipmentUS Stocks
Teradyne’s AI Test Boom Doubled Revenue – but a 61 P/E and a Softer Third-Quarter Outlook Keep the Model at Hold
Teradyne stock analysis: AI test demand doubled revenue, but a 61.06 P/E and softer Q3 guidance keep the model’s signal at Hold.
-
BiotechnologyUS Stocks
BeOne Medicines Has Doubled Off Its Low on Brukinsa’s Growth – but at 64 Times Earnings, the Model Stops at Hold
BeOne Medicines stock analysis: Brukinsa drove 29.6% revenue growth and strong margins, but a 64.06 P/E keeps the model’s signal at Hold.